ConductScience.org, home

Paper20028822

Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.

Hall BS and 3 others. Antimicrob Agents Chemother, 2010. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. Papers, record 20028822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028822

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploiting the drug-activating properties of a novel trypanosomal nitroreductase.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.85
iCite
Revised in PubMed
2021-10-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hall BSBelinda S
2Wu XXinghua
3Hu LLongqin
4Wilkinson SRShane R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NitroreductasesMajor topic
Phosphoramide MustardsMajor topic
Trypanocidal AgentsMajor topic
Trypanosoma brucei bruceiMajor topic
Animals
Cell Line
Enzyme Activation
Humans
Oxidation-Reduction
Parasitic Sensitivity Tests
Structure-Activity Relationship
Substrate Specificity

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118688784Design of anticancer prodrugs for reductive activation.Med Res Rev2009https://conductscience.org/library/papers/18688784PubMed
22614608Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.J Parasitol1989https://conductscience.org/library/papers/2614608PubMed
318367671A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18367671PubMed
46270136Generation of free radicals induced by nifurtimox in mammalian tissues.J Biol Chem1981https://conductscience.org/library/papers/6270136PubMed
512951148Nitrobenzocyclophosphamides as potential prodrugs for bioreductive activation: synthesis, stability, enzymatic reduction, and antiproliferative activity in cell culture.Bioorg Med Chem2003https://conductscience.org/library/papers/12951148PubMed
617160135Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda.PLoS Clin Trials2006https://conductscience.org/library/papers/17160135PubMed
716821793Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.J Med Chem2006https://conductscience.org/library/papers/16821793PubMed
810879539A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.Nature2000https://conductscience.org/library/papers/10879539PubMed
93247312Evidence for the involvement of a nitrenium ion in the covalent binding of nitrofurazone to DNA.Pharm Res1988https://conductscience.org/library/papers/3247312PubMed
104941089Breakage of bacterial DNA by nitrofuran derivatives.Cancer Res1971https://conductscience.org/library/papers/4941089PubMed
1110880767Possible mechanisms underlying mammary carcinogenesis in female Wistar rats by nitrofurazone.Cancer Lett2000https://conductscience.org/library/papers/10880767PubMed
1215566399Nitroreductase: a prodrug-activating enzyme for cancer gene therapy.Clin Exp Pharmacol Physiol2004https://conductscience.org/library/papers/15566399PubMed
1318355273Reduction of polynitroaromatic compounds: the bacterial nitroreductases.FEMS Microbiol Rev2008https://conductscience.org/library/papers/18355273PubMed
146327675Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase.J Biol Chem1984https://conductscience.org/library/papers/6327675PubMed
15338576Genetics of nitrofurazone resistance in Escherichia coli.J Bacteriol1978https://conductscience.org/library/papers/338576PubMed
1618657135Nitrofurantoin: the return of an old friend in the wake of growing resistance.BJU Int2008https://conductscience.org/library/papers/18657135PubMed
1718060083Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series.PLoS Negl Trop Dis2007https://conductscience.org/library/papers/18060083PubMed
1819302136Nitrofurantoin: the return of an old friend in the wake of growing resistance.BJU Int2009https://conductscience.org/library/papers/19302136PubMed
1911751773In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.J Antimicrob Chemother2002https://conductscience.org/library/papers/11751773PubMed
2017438059A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17438059PubMed

See all 32 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
38024678In Vitro and In Vivo Trypanocidal Efficacy of Nitrofuryl- and Nitrothienylazines.ACS Omega2023https://conductscience.org/library/papers/38024678PubMed
37189384Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.Biomolecules2023https://conductscience.org/library/papers/37189384PubMed
36029434Molecular Characterization of Four Mexican Isolates of Trypanosoma cruzi and Their Profile Susceptibility to Nifurtimox.Acta Parasitol2022https://conductscience.org/library/papers/36029434PubMed
34199682In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs.Molecules2021https://conductscience.org/library/papers/34199682PubMed
33673069Nitroaromatic Antibiotics as Nitrogen Oxide Sources.Biomolecules2021https://conductscience.org/library/papers/33673069PubMed
32265579An Activatable NIR Fluorescent Rosol for Selectively Imaging Nitroreductase Activity.Sens Actuators B Chem2020https://conductscience.org/library/papers/32265579PubMed
30221468Antitrypanosomatid Pharmacomodulation at Position 3 of the 8-Nitroquinolin-2(1H)-one Scaffold Using Palladium-Catalysed Cross-Coupling Reactions.ChemMedChem2018https://conductscience.org/library/papers/30221468PubMed
27543881Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity.Eur J Med Chem2016https://conductscience.org/library/papers/27543881PubMed
27092415Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.Eur J Med Chem2016https://conductscience.org/library/papers/27092415PubMed
25580906Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.J Med Chem2015https://conductscience.org/library/papers/25580906PubMed
24676659
Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme.
Mem Inst Oswaldo Cruz2014https://conductscience.org/library/papers/24676659PubMed
24165190Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24165190PubMed
24144412Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies.Future Med Chem2013https://conductscience.org/library/papers/24144412PubMed
24012457Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.Bioorg Med Chem2013https://conductscience.org/library/papers/24012457PubMed
23946481An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.J Biol Chem2013https://conductscience.org/library/papers/23946481PubMed
23335745Evaluating 5-nitrofurans as trypanocidal agents.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23335745PubMed
23281892A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro.J Med Chem2013https://conductscience.org/library/papers/23281892PubMed
22948871Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22948871PubMed
22551809Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population.J Infect Dis2012https://conductscience.org/library/papers/22551809PubMed
22550999Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.J Med Chem2012https://conductscience.org/library/papers/22550999PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20028822

GET https://conductscience.org/api/papers/v1/20028822/references?page=2